Related Experiment Video
Updated: Feb 4, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Oleanolic Acid Inhibits Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Promoting iNOS Dimerization
Hongzhi Wang1,2, Weilong Zhong1,2, Jianmin Zhao3
1Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Abstract:
Oleanolic acid exhibits extensive pharmacologic activities and takes significant antitumor effects. Its pharmacologic mechanism, however, still remained to be further clarified. In this study, we demonstrated that oleanolic acid attenuated the migration and invasion abilities, resulting in the suppression of the epithelial-mesenchymal transition (EMT) process in liver cancer cells, and inhibited the tumor growth of the peritoneal lymphocytes-bearing mice. We further proved that inducible nitric oxide synthase (iNOS) may be the potential target of oleanolic acid. We confirmed that oleanolic acid could promote the dimerization of iNOS, activating it, and subsequently increasing the production of nitric oxide. Further experiments indicated that oleanolic acid promoted the nitration of specific proteins and consequently suppressed their EMT-related biological functions. Furthermore, it has been confirmed that oleanolic acid enhanced the antitumor effects of regorafenib in liver cancer treatment. These results deepened our understanding of the pharmacologic mechanism of the antitumor effect oleanolic acid, and the importance of nitric oxide synthetase as a therapeutic target for liver cancer treatment.
Insights
Oleanolic acid suppresses liver cancer progression by inhibiting cell migration and invasion. It targets inducible nitric oxide synthase (iNOS), enhancing antitumor effects and potentially improving cancer treatments.
Area of Science:
- Pharmacology
- Oncology
- Molecular Biology
Background:
- Oleanolic acid possesses known antitumor properties, but its precise mechanisms require further elucidation.
- Liver cancer remains a significant global health challenge, necessitating novel therapeutic strategies.
- Understanding the molecular targets of oleanolic acid is crucial for optimizing its clinical application.
Purpose of the Study:
- To investigate the pharmacologic mechanisms underlying the antitumor effects of oleanolic acid in liver cancer.
- To identify potential molecular targets of oleanolic acid, focusing on its role in cancer cell migration and invasion.
- To evaluate the synergistic effects of oleanolic acid with existing liver cancer therapies.
Main Methods:
- In vitro studies using liver cancer cell lines to assess migration, invasion, and epithelial-mesenchymal transition (EMT) markers.
- In vivo experiments using mice models to evaluate tumor growth inhibition.
- Biochemical assays to determine the interaction of oleanolic acid with inducible nitric oxide synthase (iNOS) and protein nitration.
- Combination therapy studies with regorafenib.
Main Results:
- Oleanolic acid significantly attenuated liver cancer cell migration and invasion by suppressing EMT.
- The compound inhibited tumor growth in a mouse model.
- Oleanolic acid was found to promote iNOS dimerization and activation, leading to increased nitric oxide production and subsequent protein nitration.
- Oleanolic acid enhanced the antitumor efficacy of regorafenib in liver cancer treatment.
Conclusions:
- Oleanolic acid exerts antitumor effects by inhibiting EMT and tumor growth in liver cancer.
- Inducible nitric oxide synthase (iNOS) is a key molecular target of oleanolic acid, mediating its effects through nitric oxide production and protein nitration.
- Oleanolic acid holds potential as an adjuvant therapy to enhance the effectiveness of existing treatments like regorafenib for liver cancer.
Related Concept Videos
Cooperative Allosteric Transitions
Phase Transitions
The Eukaryotic Promoter Region
Feedback Inhibition
Properties of Transition Metals
Phase Transitions: Vaporization and Condensation

